Farley J. Abad

Array ( [id] => 5677755 [patent_doc_number] => 20060183111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Primary human hepatocytes for native hepatitis C virus (HCV) replication' [patent_app_type] => utility [patent_app_number] => 11/334392 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7298 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183111.pdf [firstpage_image] =>[orig_patent_app_number] => 11334392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3788 [patent_doc_number] => 07811582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Herpes viruses for immune modulation' [patent_app_type] => utility [patent_app_number] => 11/333309 [patent_app_country] => US [patent_app_date] => 2006-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9743 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811582.pdf [firstpage_image] =>[orig_patent_app_number] => 11333309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938377 [patent_doc_number] => 20080075696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Treatment Of Hepatitis C In The Asian Population With Interferon-Beta' [patent_app_type] => utility [patent_app_number] => 11/792905 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11878 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075696.pdf [firstpage_image] =>[orig_patent_app_number] => 11792905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844889 [patent_doc_number] => 20060122368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Antigen delivery platform' [patent_app_type] => utility [patent_app_number] => 11/293654 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24170 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122368.pdf [firstpage_image] =>[orig_patent_app_number] => 11293654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5785161 [patent_doc_number] => 20060204955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Method for the production of bacterial toxins' [patent_app_type] => utility [patent_app_number] => 11/288388 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8675 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204955.pdf [firstpage_image] =>[orig_patent_app_number] => 11288388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656820 [patent_doc_number] => 20060142556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides' [patent_app_type] => utility [patent_app_number] => 11/274043 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3999 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142556.pdf [firstpage_image] =>[orig_patent_app_number] => 11274043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732812 [patent_doc_number] => 20060257929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Method for the rapid taxonomic identification of pathogenic microorganisms and their toxic proteins' [patent_app_type] => utility [patent_app_number] => 11/273356 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7827 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257929.pdf [firstpage_image] =>[orig_patent_app_number] => 11273356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602211 [patent_doc_number] => 20060292556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Method of detecting antibodies to HCV' [patent_app_type] => utility [patent_app_number] => 11/269906 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 166 [patent_figures_cnt] => 166 [patent_no_of_words] => 72048 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292556.pdf [firstpage_image] =>[orig_patent_app_number] => 11269906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352469 [patent_doc_number] => 07491489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/262044 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 8686 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491489.pdf [firstpage_image] =>[orig_patent_app_number] => 11262044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715569 [patent_doc_number] => 20060078932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes' [patent_app_type] => utility [patent_app_number] => 11/248300 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14862 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078932.pdf [firstpage_image] =>[orig_patent_app_number] => 11248300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309789 [patent_doc_number] => 20090017070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'In vitro model for hepatitis c virion production' [patent_app_type] => utility [patent_app_number] => 11/664375 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 17189 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017070.pdf [firstpage_image] =>[orig_patent_app_number] => 11664375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125511 [patent_doc_number] => 20070237782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae' [patent_app_type] => utility [patent_app_number] => 11/219890 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27797 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237782.pdf [firstpage_image] =>[orig_patent_app_number] => 11219890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785031 [patent_doc_number] => 20080138360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Vaccine Composition Against Hepatitis C Virus' [patent_app_type] => utility [patent_app_number] => 11/661217 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 10915 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138360.pdf [firstpage_image] =>[orig_patent_app_number] => 11661217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431520 [patent_doc_number] => 20100143405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Immunotherapy of virus infection' [patent_app_type] => utility [patent_app_number] => 11/661098 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15005 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143405.pdf [firstpage_image] =>[orig_patent_app_number] => 11661098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939505 [patent_doc_number] => 20080076824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Compounds That Inhibit Replication Of Human Immunodeficiency Virus' [patent_app_type] => utility [patent_app_number] => 11/660429 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 65304 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076824.pdf [firstpage_image] =>[orig_patent_app_number] => 11660429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5815246 [patent_doc_number] => 20060084793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'G-CSF polypeptides and conjugates' [patent_app_type] => utility [patent_app_number] => 11/196846 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31721 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084793.pdf [firstpage_image] =>[orig_patent_app_number] => 11196846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188394 [patent_doc_number] => 20070166702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Methods for predicting the efficacy or outcome of hcv therapy' [patent_app_type] => utility [patent_app_number] => 11/572200 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14910 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166702.pdf [firstpage_image] =>[orig_patent_app_number] => 11572200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162528 [patent_doc_number] => 07671017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Use of a combination of cyclosporine and pegylated interferon for treating hepatitis C (HCV)' [patent_app_type] => utility [patent_app_number] => 11/572110 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2773 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671017.pdf [firstpage_image] =>[orig_patent_app_number] => 11572110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903564 [patent_doc_number] => 20080112977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/571598 [patent_app_country] => US [patent_app_date] => 2005-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10005 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112977.pdf [firstpage_image] =>[orig_patent_app_number] => 11571598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5767443 [patent_doc_number] => 20060019245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'HCV variants' [patent_app_type] => utility [patent_app_number] => 11/173792 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29925 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019245.pdf [firstpage_image] =>[orig_patent_app_number] => 11173792 [rel_patent_id] =>[rel_patent_doc_number] =>)